Hematological aspects of the COVID-19 syndrome


MALKAN Ü. Y. , Haznedaroglu I. C.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, vol.26, no.12, pp.4463-4476, 2022 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 12
  • Publication Date: 2022
  • Journal Name: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Page Numbers: pp.4463-4476
  • Keywords: SARS-CoV-2, COVID-19, Hematology, RENIN-ANGIOTENSIN SYSTEM, BONE-MARROW, VENOUS THROMBOSIS, INFECTION, COMPLICATIONS, PERSPECTIVES, PNEUMONIA, PLASMA, VIRUS, CELLS
  • Hacettepe University Affiliated: Yes

Abstract

OBJECTIVE: Viral infections could complicate hematopoiesis and, in some cases, they may worsen the clinical prognosis of blood disorders. SARS-CoV-2 and COVID-19, as a viral disease, can have serious impact on the disease course of hematological neoplastic diseases and can cause hematological complications. The aim of this paper is to review the hematologic aspects of COVID-19 syndrome and the potential management options for SARS-CoV-2 including the convalescent plasma, hemostatic agents and proper anticoagulant treatment.